Dracula Technologies Secures €30M in Series A Round Valence-based Dracula Technologies has announced the successful completion of its Series A extension round, bringing the total Series A …
In the Age of Ozempic: Accessibility and Cost The effectiveness and cost of weight loss drugs like Ozempic, Wegovy, and Mounjaro have been…
Introduction to Altermagnetism Experiments have only recently confirmed the existence of altermagnetic materials, but they are already gen…
Study Claims Ozempic Lowers Biological Age Researchers reveal that GLP-1 medication Ozempic may reduce biological age, offering new hope i…
Designing Light-Filled Living Spaces In Florida, natural light is one of the state’s most abundant resources—and homeowners are increasing…
Navigating Complex Injury Cases Dealing with a serious injury case can be stressful and confusing, with nearly 70 percent of personal inju…
Requtech Expands into Satcom Infrastructure Requtech, a long-standing antenna design company, has launched a satellite communications (Sat…
New Toronto Transit Station to Open A new station serving GO Transit's Kitchener Line and UP Express is set to open in weeks. Metro…
OPPO and Ballet Philippines Partnership OPPO has announced a partnership with Ballet Philippines to promote Filipino artistry, marking the…
Fi Europe 2025: A Key Return to Paris Registration is now open for Fi Europe 2025, celebrating its 30th edition in Paris from 2-4 December…
Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study Neumora Therapeutics, Inc. has initiated a Phase 1 clinical study of N…